Applied Evidence

How best to address breast pain in nonbreastfeeding women

Author and Disclosure Information

 

References

Chasteberry. One RCT demonstrated that Vitex agnus-castus, a chasteberry fruit extract, produced significant and clinically meaningful improvement in visual analogue pain scores for mastalgia, with few adverse effects.29 Another RCT assessing breast fullness as part of the premenstrual syndrome showed significant improvement in breast discomfort for women treated with Vitex ­agnus-castus.30

Evening primrose oil (EPO). In at least one small study, EPO was effective in controlling breast pain.28 A more recent meta-analysis of all of the EPO trials including gamolenic acid (the active ingredient of EPO) showed no significant difference in mastalgia compared with placebo.31

Pharmacologic Tx options: Start with NSAIDs

Oral nonsteroidal anti-inflammatory drugs (NSAIDs) are often recommended as a first-line treatment for mastalgia and are likely effective for some women; however, there is currently insufficient evidence that oral NSAIDs (or acetaminophen) improve pain (TABLE 432-37; FIGURE 25,13,17). Nevertheless, the potential benefits are thought to outweigh the risk of adverse effects in most patients. A small RCT did demonstrate that topical diclofenac was effective in patients with cyclic and noncyclic mastalgia.38

Table of medications for mastalgia

SSRIs. A meta-analysis of 10 double-blind RCTs of SSRIs used in women with premenstrual symptoms, including 4 studies that specifically included physical symptoms such as breast pain, showed SSRIs to be more effective than placebo at relieving breast pain.35

Figure of stepwise approach to benign breast pain

Progesterones. Several studies have found topical, oral, and injected progesterone ineffective at reducing breast pain.8,36,39 However, one RCT did show topical vaginal micronized progesterone used in the luteal phase to be effective in reducing breast pain by at least 50%.36

Continue to: Oral contraceptives

Pages

Recommended Reading

Is it time to taper that opioid? (And how best to do it)
MDedge Family Medicine
Doing our part to dismantle the opioid crisis
MDedge Family Medicine
Moderately high dietary riboflavin linked to fewer migraines
MDedge Family Medicine
Posttraumatic headache may be associated with reduced pain thresholds
MDedge Family Medicine
COPD adds complexity to shared decision making for LDCT lung cancer screening
MDedge Family Medicine
CDC finds that too little naloxone is dispensed
MDedge Family Medicine
Treatment of episodic cluster headache deviates from recommendations
MDedge Family Medicine
USPSTF draft guidance calls for drug use screening
MDedge Family Medicine
MSK Clinic: Evaluating shoulder pain using IPASS
MDedge Family Medicine
CDC, SAMHSA commit $1.8 billion to combat opioid crisis
MDedge Family Medicine